IP Cases — 2025
5,670 decisions across all jurisdictions
Page 9 of 189 · 5,670 total
CooperSurgical, Inc. v.European Distribution Center Motiva BVBA, Establishment Labs S.A. and PulseLavage AB
This case concerned an infringement action filed by CooperSurgical, Inc. before the Unified Patent Court (Local Division Brussels) regarding EP 3 302 292 B1. After the European Patent Office Opposition Division revoked the patent on 30 September 2025, the Claimant withdrew the action. The Court allowed the withdrawal and assessed the costs to be reimbursed to the Defendants, ordering the Claimant to pay €105,757.90 to Defendants 1-2 and €81,423.33 to Defendant 3, while also ordering reimbursement of 60% of the court fees to the Claimant.
BARCO NV v.YEALINK (XIAMEN) NETWORK TECHNOLOGY Co. Ltd. and YEALINK (EUROPE) NETWORK TECHNOLOGY BV
Infringement proceedings concerning EP 3 732 827 before the Local Division Brussels. YEALINK filed a Preliminary Objection challenging the territorial competence of the Brussels Local Division under Article 33(1)(a) UPCA. After the Court of Appeal confirmed the Brussels Local Division's territorial competence in a related cross-appeal, YEALINK withdrew its Preliminary Objection, and the Court closed the preliminary objection proceedings.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect seeks an IPR of Align’s 11,369,456 patent covering clear‑aligner treatment‑plan software. The petition alleges obviousness over four prior‑art references and requests the Board to institute review and invalidate claims 1‑19.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect has filed an IPR petition seeking cancellation of all 24 claims of Align Technology’s orthodontic treatment‑planning patent (US 10,524,879), alleging obviousness over four prior‑art references. The petition argues that the round‑tripping collision‑avoidance technique is well‑known.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect has filed an IPR petition seeking to invalidate claims 1‑20 of Align Technology’s orthodontic treatment‑planning patent, arguing the claims are obvious over four prior‑art references.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating challenged Align Technology's dental treatment planning patent (11,369,456 B2) before the PTAB. The Board found a reasonable likelihood of prevailing on Ground 1, based on obviousness over Chishti-511, Chishti-876, and Sachdeva.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating lost its IPR challenge against Align Technology's '879 patent in a PTAB decision focused on obviousness. The Board rejected the petitioner’s argument that combining prior art references would render the claims obvious, upholding the validity of the challenged technology in orthodontics.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating lost its IPR challenge against Align Technology regarding dental treatment planning technology. The PTAB ruled that the claimed obviousness over prior art was not demonstrated, upholding the validity of the patent claims.
Castrol Limited v.Vivek Pratap Singh
The Delhi High Court allowed Castrol Limited's appeal, recognizing that the respondent was engaged in blatant counterfeiting of its motor oil brand. The court emphasized the severe public safety risk associated with substandard counterfeit engine oils. Consequently, the court directed the appointment of a Local Commissioner to inventory and take custody of the infringing products, granting immediate relief to protect the appellant's market and consumers.
KT&G Corporation (Xx) v.YY
In a significant ruling concerning trademark infringement in the tobacco sector, the Delhi High Court granted an interim injunction and permitted the appointment of Local Commissioners. The plaintiff, KT&G Corporation, sought protection for its renowned ESSE brand against counterfeiting. The court facilitated the execution of commissions to seize infringing products while ensuring procedural fairness, setting the stage for a full trial.
Akashdeep Enterprises Through Lrs & Anr v.Ella Foundation
The Delhi High Court granted an interim injunction in favor of Akashdeep Enterprises against Ella Foundation. The suit, filed under the Trademark Act, sought protection against groundless infringement threats. The court found that the likelihood of confusion between the parties' distinct goods (household products) and services (medicine/research) was minimal. Consequently, the Defendant was restrained from taking coercive steps, such as de-listing Plaintiffs' products on e-commerce platforms, until the final hearing.
Transcend Information Inc. v.Truesight Communications LLC
Transcend Information has filed an IPR petition challenging all 18 claims of Truesight Communications' 2015 patent on secure SD‑card content transfer, asserting obviousness over multiple prior‑art references. The petition also argues that the Board should not deny institution despite related Texas litigation.
M/S. Anup Kumar Biswas v.M/S. S. H. Biri Factory And Anr.
M/S. Anup Kumar Biswas filed an application seeking the rectification of a Copyright Registration held by M/S. S. H. Biri Factory And Anr., alleging that the registered label was deceptively similar to their own trade name and infringed upon their rights. The petitioner claimed the registration was obtained surreptitiously without notice. Given the respondent's willingness to have the matter heard afresh after proper notice, the Court cancelled the impugned registration and remanded the case back to the Copyright Registrar for a fresh decision.
Incyte Holdings Corporation v.Bigbear Pharmaceutical (Lao) Co., Ltd
The Plaintiffs filed a suit seeking permanent injunction against the Defendants for infringing Indian Patent No. 269841 related to Ruxolitinib compounds. The court passed several orders granting exemptions from pre-institution mediation and advance service, and appointed Local Commissioners to inspect the alleged infringing activities.
Incyte Holdings Corporation v.Incepta Pharmaceuticals Ltd.
The Plaintiffs filed a suit seeking permanent injunction against Defendants for infringing Indian Patent No. 269841, which covers Ruxolitinib compounds (JAKAVI®). The court passed several orders granting exemptions to the Plaintiffs regarding mediation, identity masking, and advance service, while also directing the execution of Local Commissions to investigate the alleged infringement.
Incyte Holdings Corporation v.Lucius Pharmaceuticals Co., Ltd.
The Plaintiffs filed a suit seeking a permanent injunction to restrain the Defendants from infringing Indian Patent No. 269841 concerning Ruxolitinib Compounds. The court granted various exemptions sought by the plaintiffs, including exemption from pre-institution mediation, and proceeded with appointing Local Commissioners for the execution of the patent.
Windhager Handelsgesellschaft m.b.H. v.bellissa HAAS GmbH
The Court of Appeal of the Unified Patent Court rejected Windhager's application for suspensive effect of its appeal against a decision of the Local Chamber Mannheim, which had largely upheld bellissa's infringement claim regarding EP 2 223 589 and dismissed Windhager's revocation counterclaim. The court found that Windhager failed to demonstrate that the first instance decision contained obvious errors or that its interest in staying enforcement outweighed bellissa's interest in preventing patent infringement. The pending new revocation action before the Central Chamber Milan was deemed irrelevant at this stage.
Yangtze Memory Technologies Company, Ltd. et al. v.Micron Technology, Inc. et al.
Yangtze Memory Technologies seeks Director Review of the PTAB’s denial to institute an IPR against Micron’s 10,475,737 flash‑memory patent, arguing the Board misapplied settled‑expectations analysis and violated APA due‑process rules.
Yangtze Memory Technologies Company, Ltd. et al. v.Micron Technology, Inc. et al.
Micron Technology opposes Yangtze Memory’s request for Director Review of a PTAB decision that denied institution of an IPR on Micron’s 3D NAND patent. The response argues the petitioner’s claims of no parallel litigation and examiner error are unsupported and that procedural challenges were waived.
Yangtze Memory Technologies Company, Ltd. et al. v.Micron Technology, Inc. et al.
The USPTO Director denied Yangtze Memory's request for Director Review of the PTAB's denial of institution in four IPRs, including the case involving Micron's patent 10,475,737.
Advanced Micro Devices, Inc. et al. v.XtreamEdge, Inc. et al.
AMD and Pensando’s IPR petition targeting XtreamEdge’s modular data‑processing patent is met with a robust preliminary response arguing that the cited prior art does not disclose key claim limitations, prompting a request for discretionary denial of institution.
Advanced Micro Devices, Inc. et al. v.XtreamEdge, Inc. et al.
The USPTO has initiated a Director review of three AMD‑related IPRs after the Patent Owner claimed the Petitioners breached a Sotera stipulation by litigating the same invalidity arguments in district court. The proceedings are stayed pending briefing and a forthcoming opinion.
Advanced Micro Devices, Inc. et al. v.XtreamEdge, Inc. et al.
AMD and its co‑petitioner withdrew their request for rehearing in IPR2025‑00486. The Board granted the motion, ending the rehearing request and returning the case to the Board for further action.
Advanced Micro Devices, Inc. et al. v.XtreamEdge, Inc. et al.
AMD and Pensando have filed an IPR petition challenging XtreamEdge’s ’753 patent covering blade‑server packet identifiers and memory arrangements, arguing the claims are obvious over multiple prior‑art references.
Yangtze Memory Technologies Company, Ltd. et al. v.Micron Technology, Inc. et al.
Yangtze Memory Technologies petitions the PTAB to invalidate 18 claims of Micron's 3D NAND patent, arguing anticipation and obviousness over four prior‑art references. The petition seeks institution and cancellation of the claims.
Advanced Micro Devices, Inc. et al. v.XtreamEdge, Inc. et al.
Advanced Micro Devices (AMD) and Pensando Systems successfully convinced the PTAB that XtreamEdge's network testing claims are likely obvious under 35 U.S.C. § 103. The Board issued an institution decision, moving the dispute toward trial on grounds of obviousness over multiple prior art references.
Novo Nordisk As v.Dr. Reddys Laboratories Limited & Anr.
Novo Nordisk filed a suit alleging infringement of its patent (IN'697) covering Semaglutide, a GLP-1 analogue used for diabetes and obesity. The Plaintiff sought an interim injunction to restrain the Defendants from importing or dealing in the compound. The Court ultimately dismissed the application, finding that the Plaintiff failed to establish a prima facie case for the grant of relief.
M/s. Shilpa Medicare Limited v.M/s. Salus Pharmaceutical & anr.
M/s. Shilpa Medicare Limited filed a commercial appeal against an order, seeking condonation of delay due to initial incorrect nomenclature. The court allowed the delay condonation, noting that procedural rules are handmaids of justice. Subsequently, the court set aside a single judge's order and remanded the matter for consideration on merits, emphasizing continuous infringement.
XX v.Y
The Delhi High Court allowed the commercial suit filed by XX against Y, which alleges infringement of trademarks and designs related to 'HERO Genuine engine oil.' The court granted several procedural reliefs, including masking party identities and exempting the plaintiffs from pre-institution mediation due to the urgent nature of the relief sought. Crucially, the court permitted the appointment of a Local Commissioner to inspect the premises, seize infringing stock, and ascertain its value, paving the way for immediate interim protection.
Ganraj Enterprises v.Land Mark Crafts Pvt. Ltd & Anr.
The Delhi High Court issued an order allowing the Respondent No. 1 to file several additional documents in the ongoing trademark litigation. The application sought modification of a prior order, primarily to bring on record evidence concerning the change of ownership of trademarks and detailed arguments regarding the alleged deceptive similarity between the parties' marks. This procedural step allows the court to consider complex issues related to assignment dates and examination objections.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.